[HTML] frontiersin.org

[HTML][HTML] 2-Deoxy-D-Glucose and its derivatives for the COVID-19 treatment: an update

Z Huang, VP Chavda, LK Vora, N Gajjar… - Frontiers in …, 2022 - frontiersin.org
Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐
CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles. Currently, no …
被引用次数：29 相关文章

2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update

Z Huang, VP Chavda, LK Vora… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Treatment choices for the" severe acute respiratory syndrome-related coronavirus-2 (SARS-
CoV-2)" are inadequate, having no clarity on efficacy and safety profiles. Currently, no …

2-deoxy-d-glucose and its derivatives for the COVID-19 treatment: an update

Z Huang, VP Chavda, L Vora, N Gajjar… - Frontiers in …, 2022 - vuir.vu.edu.au
Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐
CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles. Currently, no …

2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update.

Z Huang, VP Chavda, LK Vora, N Gajjar… - Frontiers in …, 2022 - europepmc.org
Abstract Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐
2 (SARS‐CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles …

2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update

Z Huang, VP Chavda, LK Vora, N Gajjar… - Frontiers in …, 2022 - pure.qub.ac.uk
Abstract Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐
2 (SARS‐CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles …

2-Deoxy-D-glucose and its derivatives for the COVID-19 treatment: an update.

Z Huang, VP Chavda, LK Vora, N Gajjar… - 2022 - cabidigitallibrary.org
Abstract Treatment choices for the" severe acute respiratory syndrome-related coronavirus-2
(SARS-CoV-2)" are inadequate, having no clarity on efficacy and safety profiles. Currently …
[PDF] scienceopen.com

[PDF][PDF] 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update. Front. Pharmacol. 13: 899633. doi: 10.3389/fphar. 2022.899633

Z Huang, VP Chavda, LK Vora, N Gajjar… - … www. frontiersin. org, 2022 - scienceopen.com
Treatment choices for the “severe acute respiratory syndrome-related coronavirus-2 (SARS-
CoV-2)” are inadequate, having no clarity on efficacy and safety profiles. Currently, no …
[HTML] nih.gov

[HTML][HTML] 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update

Z Huang, VP Chavda, LK Vora, N Gajjar… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Abstract Treatment choices for the “severe acute respiratory syndrome‐related coronavirus‐
2 (SARS‐CoV‐2)” are inadequate, having no clarity on efficacy and safety profiles …